Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Marques, Mirna B ^a   Perre, Sarah V ^a   Aertgeerts, Annelies ^a   Derde, Sarah ^a   Güiza, Fabian ^a   Casaer, Michael P ^a   Hermans, Greet ^a   Van den Berghe, Greet ^a   Langouche, Lies ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CCAAT ENHANCER BINDING PROTEIN BETA; CD163 ANTIGEN; CYCLINE; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIETARY INTAKE; FAT FREE MASS; FAT MASS; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INTRAABDOMINAL FAT; LIPOLYSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); AGED; ANIMAL; C57BL MOUSE; MACROPHAGE ACTIVATION; METABOLISM; MIDDLE AGED; NUTRITIONAL STATUS; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADIPOGENESIS; ADIPOSE TISSUE; AGED; ANIMALS; CRITICAL ILLNESS; FEMALE; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; NUTRITIONAL STATUS;

EID: 84883614835     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12887     Document Type: Article

References (48)

1. Hutagalung R, Marques J, Kobylka K, Zeidan M, Kabisch B, Brunkhorst F, Reinhart K, Sakr Y. The obesity paradox in surgical intensive care unit patients. Intensive Care Med 2011, 37:1793-1799. 10.1007/s00134-011-2321-2, 21818652.
2. Peake SL, Moran JL, Ghelani DR, Lloyd AJ, Walker MJ. The effect of obesity on 12-month survival following admission to intensive care: a prospective study. Crit Care Med 2006, 34:2929-2939.
3. Ray DE, Matchett SC, Baker K, Wasser T, Young MJ. The effect of body mass index on patient outcomes in a medical ICU. Chest 2005, 127:2125-2131. 10.1378/chest.127.6.2125, 15947330.
4. Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 2012, 81:715-736. 10.1146/annurev-biochem-052110-115718, 22463691.
5. Langouche L, Vander Perre S, Thiessen S, Gunst J, Hermans G, D'Hoore A, Kola B, Korbonits M, Van den Berghe G. Alterations in adipose tissue during critical illness: an adaptive and protective response?. Am J Respir Crit Care Med 2010, 182:507-516. 10.1164/rccm.200909-1395OC, 20442437.
6. Langouche L, Marques MB, Ingels C, Gunst J, Derde S, Vander Perre S, D'Hoore A, Van den Berghe G. Critical illness induces alternative activation of M2 macrophages in adipose tissue. Crit Care 2011, 15:R245. 10.1186/cc10503, 3334796, 22018099.
7. Roberts R, Hodson L, Dennis AL, Neville MJ, Humphreys SM, Harnden KE, Micklem KJ, Frayn KN. Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans. Diabetologia 2009, 52:882-890. 10.1007/s00125-009-1300-4, 19252892.
8. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604. 10.1016/j.immuni.2010.05.007, 20510870.
9. Curat CA, Miranville A, Sengenes C, Diehl M, Tonus C, Busse R, Bouloumie A. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004, 53:1285-1292. 10.2337/diabetes.53.5.1285, 15111498.
10. Bosco MC, Puppo M, Blengio F, Fraone T, Cappello P, Giovarelli M, Varesio L. Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 2008, 213:733-749. 10.1016/j.imbio.2008.07.031, 18926289.
11. Hoffstedt J, Arner P, Hellers G, Lonnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res 1997, 38:795-804.
12. Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G. Early versus late parenteral nutrition in critically ill adults. N Engl J Med 2011, 365:506-517. 10.1056/NEJMoa1102662, 21714640.
13. Baker CC, Chaudry IH, Gaines HO, Baue AE. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983, 94:331-335.
14. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009, 4:31-36. 2754226, 19131954.
15. Singleton KD, Wischmeyer PE. Distance of cecum ligated influences mortality, tumor necrosis factor-alpha and interleukin-6 expression following cecal ligation and puncture in the rat. Eur Surg Res 2003, 35:486-491. 10.1159/000073387, 14593232.
16. Hollenberg SM, Dumasius A, Easington C, Colilla SA, Neumann A, Parrillo JE. Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 2001, 164:891-895. 10.1164/ajrccm.164.5.2010073, 11549551.
17. Tallarida RJ, Cowan A, Raffa RB. On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data. Drug Alcohol Depend 2010, 109:126-129. 10.1016/j.drugalcdep.2009.12.014, 20061095.
18. Langford DJ, Bailey AL, Chanda ML, Drummond TE, Echols S, Glick S, Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, Matsumiya L, Sorge RE, Sotocinal SG, Tabaka JM, Wong D, van den Maagdenberg AM, Ferrari MD, Craig KD, Mogil JS. Coding of facial expressions of pain in the laboratory mouse. Nat Methods 2010, 7:447-449. 10.1038/nmeth.1455, 20453868.
19. Casaer MP, Hermans G, Wilmer A, Van den Berghe G. Impact of early parenteral nutrition completing enteral nutrition in adult critically ill patients (EPaNIC trial): a study protocol and statistical analysis plan for a randomized controlled trial. Trials 2011, 12:21. 10.1186/1745-6215-12-21, 3033837, 21261975.
20. Mebis L, Eerdekens A, Güiza F, Princen L, Derde S, Vanwijngaerden YM, Vanhorebeek I, Darras VM, Van den Berghe G, Langouche L. Contribution of nutritional deficit to the pathogenesis of the nonthyroidal illness syndrome in critical illness: a rabbit model study. Endocrinology 2012, 153:973-984. 10.1210/en.2011-1411, 22166982.
21. Bjorntorp P. Effects of age, sex, and clinical conditions on adipose tissue cellularity in man. Metabolism 1974, 23:1091-1102. 10.1016/0026-0495(74)90076-6, 4607783.
22. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005, 115:2277-2286. 10.1172/JCI25385, 1180545, 16075063.
23. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010, 18:1283-1288. 10.1038/oby.2009.419, 19927138.
24. Chinetti-Gbaguidi G, Staels B. Macrophage polarization in metabolic disorders: functions and regulation. Curr Opin Lipidol 2011, 22:365-372. 10.1097/MOL.0b013e32834a77b4, 3565956, 21825981.
25. Vanhorebeek I, Van den Berghe G. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients. Curr Opin Pharmacol 2004, 4:621-628. 10.1016/j.coph.2004.07.007, 15525554.
26. Hart DW, Wolf SE, Herndon DN, Chinkes DL, Lal SO, Obeng MK, Beauford RB, Mlcak RP. Energy expenditure and caloric balance after burn: increased feeding leads to fat rather than lean mass accretion. Ann Surg 2002, 235:152-161. 10.1097/00000658-200201000-00020, 1422407, 11753055.
27. Jeevanandam M, Young DH, Schiller WR. Influence of parenteral nutrition on rates of net substrate oxidation in severe trauma patients. Crit Care Med 1990, 18:467-473. 10.1097/00003246-199005000-00001, 2109673.
28. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987, 27:262-266. 10.1097/00005373-198703000-00006, 3104621.
29. Cree MG, Wolfe RR. Postburn trauma insulin resistance and fat metabolism. Am J Physiol Endocrinol Metab 2008, 294:E1-E9.
30. Vanhorebeek I, Gunst J, Derde S, Derese I, Boussemaere M, Guiza F, Martinet W, Timmermans JP, D'Hoore A, Wouters PJ, Van den Berghe G. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab 2011, 96:E633-E645. 10.1210/jc.2010-2563, 21270330.
31. Ahfeldt T, Schinzel RT, Lee YK, Hendrickson D, Kaplan A, Lum DH Camahort R, Xia F, Shay J, Rhee EP, Clish CB, Deo RC, Shen T, Lau FH, Cowley A, Mowrer G, Al-Siddiqi H, Nahrendorf M, Musunuru K, Gerszten RE, Rinn JL, Cowan CA. Programming human pluripotent stem cells into white and brown adipocytes. Nat Cell Biol 2012, 14:209-219. 10.1038/ncb2411, 3385947, 22246346.
32. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis 2000, 181(Suppl 3):S462-S472.
33. Van den Berghe G. Intensive insulin therapy in the ICU--reconciling the evidence. Nat Rev Endocrinol 2012, 8:374-378.
34. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjögren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lönn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006, 20:1540-1542. 10.1096/fj.05-5678fje, 16754744.
35. Collins S, Cao W, Robidoux J. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol 2004, 18:2123-2131. 10.1210/me.2004-0193, 15243132.
36. Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989, 245:1118-1121. 10.1126/science.2570461, 2570461.
37. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911. 10.2337/db06-0911, 17395738.
38. Kvetnansky R, Ukropec J, Laukova M, Manz B, Pacak K, Vargovic P. Stress stimulates production of catecholamines in rat adipocytes. Cell Mol Neurobiol 2012, 32:801-813. 10.1007/s10571-012-9822-6, 3419009, 22402834.
39. Vargovic P, Ukropec J, Laukova M, Cleary S, Manz B, Pacak K, Kvetnansky R. Adipocytes as a new source of catecholamine production. FEBS Lett 2011, 585:2279-2284. 10.1016/j.febslet.2011.06.001, 21689652.
40. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964. 10.1038/nri1733, 16322748.
41. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555. 10.1016/S1471-4906(02)02302-5, 12401408.
42. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab 2006, 4:13-24. 10.1016/j.cmet.2006.05.011, 1904486, 16814729.
43. Prieur X, Mok CY, Velagapudi VR, Nunez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Orešič M, Ricote M, Vidal-Puig A. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011, 60:797-809. 10.2337/db10-0705, 3046840, 21266330.
44. Vidal-Puig A, Unger RH. Special issue on lipotoxicity. Biochim Biophys Acta 2010, 1801:207-208. 10.1016/j.bbalip.2009.12.010, 20045080.
45. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L, Red Eagle A, Vats D, Brombacher F, Ferrante AW, Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120. 10.1038/nature05894, 2587297, 17515919.
46. Bouhlel MA, Derudas B, Rigamonti E, Dievart R, Brozek J, Haulon S, Zawadzki C, Jude B, Torpier G, Marx N, Staels B, Chinetti-Gbaguidi G. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6:137-143. 10.1016/j.cmet.2007.06.010, 17681149.
47. Shapiro H, Lutaty A, Ariel A. Macrophages, meta-inflammation, and immuno-metabolism. ScientificWorldJournal 2011, 11:2509-2529. 3253544, 22235182.
48. Nagy L, Szanto A, Szatmari I, Szeles L. Nuclear hormone receptors enable macrophages and dendritic cells to sense their lipid environment and shape their immune response. Physiol Rev 2012, 92:739-789. 10.1152/physrev.00004.2011, 22535896.